SOPHiA GENETICS S.A.

IEX • Healthcare • Health Information Services • Quote as of 11/10/2026 15:59

Company Profile

IndustryHealth Information Services

SectorHealthcare

ExchangeIEX

Market Capitalization611.6 mln

Float61.78 mln

Earnings Date03/09/2027

Piotroski F-Score

3 / 9

Below average

Beneish M-Score

-2.7

Likely reliable

Relative Strength

78 / 100

Strongly outperforming

Debt / Equity

0.89

Moderate leverage

Pre-Tax Margin

-89%

Severely loss-making

ROE

-133

Deeply negative

Business Description

Founded in 2011 and headquartered in Rolle, Switzerland, SOPHiA GENETICS helps medical institutions and drug developers make better sense of complex patient data. The company's core offering is a web-based platform that processes and interprets information from multiple diagnostic sources, turning raw data into actionable clinical insights. Its tools are used by hospitals, laboratories, and life sciences organizations across Europe, North America, Latin America, and the Asia-Pacific region.

Key Fundamentals

EPS-1.09

ROE-133

RPS1.22

ROIC-86.24

ROA-46.79

Interest Cover-11.13

EBITDA, mln-63.38

EV / EBITDA-8.28

EV / EBIT-7.06

Revenue, mln90.97

EV / Revenue5.77

Quote Details

Last 7.84

Change 0.38 (5.09%)

Open 7.89

Volume 792,845

Turnover 6,215,905

Average Volume 606,916

Financial Ratios

Pre-Tax Profit Margin-89

Leverage Ratio2.70

Current Ratio2.29

Price / Book8.20

Price / Tangible Book17.26

Debt / Equity0.89

Price / Sales5.38

Financial Strength

Altman Z-Score-1.72

Piotroski F-Score 3 / 9

Beneish M-Score-2.7

Short Ratio1.35

Short % of Float1.24

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	13.46%	95 / 100
1 Month	8.59%	82 / 100
2 Months	24.44%	95 / 100
6 Months	69.33%	97 / 100
1 Year	78.18%	93 / 100